Biocon

Biocon gets USFDA nod for generic anti-cancer drug

Biocon gets USFDA nod for generic anti-cancer drug

07 Feb 2024

1 min read

No plans to evaluate divestment options for API biz: Biocon

No plans to evaluate divestment options for API biz: Biocon

15 Dec 2023

1 min read

Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY

Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY

11 Aug 2023

2 min read

Biocon starts clinical study to evaluate efficacy of itolozumab

Biocon starts clinical study to evaluate efficacy of itolozumab

14 Dec 2022

1 min read

Biocon Q4: Consolidated revenue growth recorded at Rs 2,476 crore

Biocon Q4: Consolidated revenue growth recorded at Rs 2,476 crore

29 Apr 2022

3 min read

Biocon, Mylan may merge biosimilar business: Report

Biocon, Mylan may merge biosimilar business: Report

10 Dec 2021

1 min read

Read More

DT Next

www.dtnext.in